Publicaciones en colaboración con investigadores/as de Hospital Universitario San Cecilio (14)

2022

  1. Saposin C, Key Regulator in the Alpha-Synuclein Degradation Mediated by Lysosome

    International Journal of Molecular Sciences, Vol. 23, Núm. 19

2021

  1. Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

    Nature Communications, Vol. 12, Núm. 1

  2. Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage

    Nature Communications, Vol. 12, Núm. 1

2019

  1. SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease

    Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344

  2. The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight

    Movement Disorders, Vol. 34, Núm. 12, pp. 1851-1863

2016

  1. Analysis of the genetic variability in Parkinson's disease from Southern Spain

    Neurobiology of Aging, Vol. 37, pp. 210.e1-210.e5

  2. Genome-wide assessment of Parkinson's disease in a Southern Spanish population

    Neurobiology of Aging, Vol. 45, pp. 213.e3

2014

  1. Proteomic biomarkers in Parkinson's disease

    Revista de Neurologia, Vol. 58, Núm. 4, pp. 166-174

2011

  1. Oxidative stress and aminopeptidases in Parkinson's disease patients with and without treatment

    Neurodegenerative Diseases, Vol. 8, Núm. 3, pp. 109-116

2010

  1. Plasma α-synuclein in patients with Parkinson's disease with and without treatment

    Movement Disorders, Vol. 25, Núm. 4, pp. 489-493

2006

  1. Evaluation of the Spanish version of the Memory Impairment Screen

    Revista de Neurologia, Vol. 43, Núm. 1, pp. 15-19

  2. Plasma lipid peroxidation in sporadic Parkinson's disease. Role of the L-dopa

    Journal of the Neurological Sciences, Vol. 240, Núm. 1-2, pp. 31-36

2005

  1. Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1)

    Pharmacogenomics Journal, Vol. 5, Núm. 2, pp. 135-141

  2. Dopaminergic function in a family with the PARK6 form of autosomal recessive Parkinson's syndrome

    Journal of Neural Transmission, Vol. 112, Núm. 10, pp. 1345-1353